Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values

Normally I'd agree - but on 3yr paper

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
10nisman Member Profile
 
Followed By 6
Posts 1,507
Boards Moderated 0
Alias Born 10/26/03
160x600 placeholder
U.s. Stocks Jump On Fed Reassurance
Stocks extended their gains into afternoon trading, boosted for a second session by reassurances from the Federal Reserve that it is in no rush to raise interest rates. The Dow industrials were up 270 points.
More Top Equities Stories Of The Day
Deezer Names New CEO Before Full U.S. Launch
Repsol to Buy Talisman Energy for $8.3 Billion --Update
BofA Whistleblower to Get Nearly $58 Million--Filing
Sprint to Face Record Fine Over Unauthorized Customer Charges
ADR Shares End Lower; BT Group Shares Trade Actively
U.S. Hot Stocks: Hot Stocks to Watch
U.K. to Sell Part of Lloyds Stake--2nd Update
Oracle Beats Street View for First Time in a Year
10nisman   Thursday, 09/23/10 12:08:13 PM
Re: wallstarb post# 104887
Post # of 184826 
Quote:
Normally I'd agree - but on 3yr paper it doesnt have the duration for a longer term investment, and unless MSFT is buying junk bonds with it I really dont see the point for them. Perhaps an acquisition on the horizon - or maybe they are buying some CMOs

The vast majority of MSFT's cash is overseas and thus to get around paying taxes to repatriate it they chose to issue debt at insanely attractive levels. MSFT will likely use the cash to pay its dividend and buy-back shares.

10nis

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist